Fibclot

Human Fibrinogen (Fibclot) is a clotting factor used to manage bleeding disorders. This intravenous medication supports blood coagulation, aiding in wound healing and surgical recovery.

Human Fibrinogen, also known as Fibclot, is primarily used to treat bleeding disorders where the body lacks sufficient fibrinogen. It is often administered intravenously to promote blood clotting and manage excessive bleeding during surgeries or trauma. This medication is crucial for patients with congenital fibrinogen deficiency or those undergoing procedures that require rapid clotting.

Common effects of Human Fibrinogen may include localized reactions at the injection site, such as redness or swelling. Some individuals might experience mild allergic reactions. Severe side effects are rare but can occur, and medical attention should be sought if unusual symptoms arise.

Human Fibrinogen should be handled with care, ensuring proper storage and administration by healthcare professionals. Patients with a history of allergic reactions to fibrinogen or its components should use this medication with caution. Always follow the guidance of a healthcare provider when using this product.

Human Fibrinogen may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements might also influence the effectiveness of this medication.